Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Second life for pharma's secret drug discovery data
A new and powerful Australian artificial intelligence model can comb through data from confidential pharmaceutical trials – both failed and successful – to help big pharma companies avoid wasting their resources on already…
Pharma pushes for higher European drug prices, Trump or no Trump
Just over a year ago, US President Trump issued an executive orderExternal link calling for US drug prices to align with so-called Most-Favoured Nation (MFN) prices – those paid in other developed countries. On average, Americans pay three…
CSL names British pharma executive as new CEO
Healthcare giant CSL has named British pharmaceutical executive Deborah Waterhouse as its new chief executive following a six-month global search. Waterhouse, a senior executive at British company GSK, will replace interim chief executive Gordon…
Sun Pharma Board Authorizes Up to ₹10,000 Crore in Bonds
Sun Pharmaceutical Industries Limited (Sun Pharma) has authorized up to ₹10,000 crore in bonds, which Reuters and The Economic Times reported would refinance borrowing for its proposed Organon & Co. acquisition. The Oct. 12 board decision…
Sun Pharma Shares Recover From Intraday Dip Before Oct. 30 Results
Sun Pharmaceutical Industries Limited (Sun Pharma) shares closed Oct. 21 at ₹1,745.10 on the National Stock Exchange of India (NSE), recovering from an intraday decline ahead of the company's Oct. 30 results announcement. The Economic Times'…
RESEARCH CAPITAL INITIATES ANALYST COVERAGE OF LSL PHARMA GROUP
BOUCHERVILLE, QC, Oct. 21, 2026 /CNW/ -- LSL PHARMA GROUP INC. (TSXV: LSL) (the 'Corporation' or 'LSL Pharma'), a Canadian integrated pharmaceutical company, today announced that Research Capital Corporation has initiated equity research coverage…
Orchid Pharma Board Approves Exploring a Raise of Up to Rs 600 Crore
Orchid Pharma Limited's board approved exploring a capital raise of up to Rs 600 crore, while Infosys expanded its Truist partnership, putting financing and technology work in focus for Indian investors Wednesday, Oct. 21. Orchid's authorization…
Skin Cancer Guidelines Add UNLOXCYT as Category 2A Option, Sun Pharma Says
Sun Pharmaceutical Industries Limited (Sun Pharma) said the National Comprehensive Cancer Network (NCCN) gave UNLOXCYT a Category 2A recommendation for locally advanced skin cancer, a designation that may inform U.S. coverage decisions. According…
Apothecary Pharma Recalls Tirzepatide Vials Nationwide
A Cary, North Carolina pharmacy is recalling 22 vials of compounded tirzepatide after federal regulators said the company cannot assure the products were made sterile, and the recall has already shipped nationwide. Apothecary Pharma LLC initiated…
Tech Stocks Took a Hit-These 2 Pharma Stocks Are Near New Highs
While attention has focused on the brutal sell-off tearing through the technology sector and the AI trade, something notable has been happening in another corner of the market. The biotech and pharmaceutical sector has held its ground and…
BridgeBio Pharma (BBIO) Expected to Release Quarterly Earnings on Wednesday
BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) is expected to be releasing its Q3 2026 results after the market closes on Wednesday, October 28th. Analysts expect the company to post earnings of ($0.5437) per share and revenue of $288.74 million…
Why Agentic AI Is The Future Of Continuous Improvement
Andreas Eschbach is the founder and CEO of eschbach, a software company that helps production teams work smarter and enhance collaboration. Continuous improvement (CI) has always been the goal in process manufacturing. In practice, however…
Spyglass Pharma, Inc. (NASDAQ:SGP) Stock Has Average Price Target of $44.00
Shares of Spyglass Pharma, Inc. (NASDAQ:SGP - Get Free Report) have been given an average recommendation of 'Moderate Buy' by the nine brokerages that are currently covering the firm, Marketbeat Ratings reports. One equities research analyst has…
Spyglass Pharma (NASDAQ:SGP) Earns 'Buy' Rating from HC Wainwright
Spyglass Pharma (NASDAQ:SGP - Get Free Report)'s stock had its 'buy' rating reaffirmed by HC Wainwright in a note issued to investors on Wednesday, Benzinga reports. They presently have a $37.00 target price on the stock. HC Wainwright's target…
OpenAI acquires startup Orchestra Bio to beef up its biotech business
OpenAI on Tuesday acquired a four-year-old AI biotech software startup called Orchestra Bio, the company announced via its website. Terms of the deal were not disclosed, but the startup had reportedly raised around $20 million as of 2025 from…
Receive a Daily briefing on Pharma Industry News
Get Started